The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Life's End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05644262
Recruitment Status : Recruiting
First Posted : December 9, 2022
Last Update Posted : March 27, 2024
Sponsor:
Collaborators:
Medical University of South Carolina
Alzheimer's Clinical Trials Consortium
Alzheimer's Therapeutic Research Institute
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Paul Aisen, University of Southern California

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2025